<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36782252</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Feb</Month><Day>12</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>Epstein&#x2012;Barr virus and human herpesvirus 6 infection in patients with systemic lupus erythematosus.</ArticleTitle><Pagination><StartPage>29</StartPage><MedlinePgn>29</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">29</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-023-01987-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic lupus erythematosus (SLE) is a complex autoimmune disease, and the etiology is still unclear. Some studies have indicated that viral infection might contribute to the development of SLE.</AbstractText><AbstractText Label="METHODS">A total of 105 individuals with SLE and 110 matched healthy controls were tested for EBV-specific DNA fragments in peripheral blood monocytes by PCR-Southern blotting. The expression of EBV-encoded genes was determined by RT-PCR and Southern blotting in EBV-positive patients. Serum EBV-specific IgM antibody was determined by ELISA. HHV-6 DNA in peripheral blood monocytes of those SLE patients and normal controls was tested by nested PCR.</AbstractText><AbstractText Label="RESULTS">Statistical analysis showed that the EBV-positive rate of SLE patients was significantly higher than that of the control group (&#x3c7;<sup>2</sup>&#x2009;=&#x2009;87.329, P&#x2009;=&#x2009;0), while the difference in the HHV-6-positive rate between the two groups was not significant (P&#x2009;&gt;&#x2009;0.05). An association of EBV and HHV-6 positivity in SLE patients was found (P&#x2009;=&#x2009;0, r&#x2009;=&#x2009;0.38). The EBV IgM level was significantly higher in SLE patients than in healthy controls (&#x3c7;<sup>2</sup>&#x2009;=&#x2009;25.184, P&#x2009;=&#x2009;0). Forty-two of the 75 EBV DNA-positive specimens were positive for EBNA2 mRNA, and an association between EBV EBNA2 mRNA and anti-Sm antibody positivity was found (P&#x2009;=&#x2009;0, r&#x2009;=&#x2009;0.409). LMP1 mRNA was positive in 2 SLE patients with active phase, and no LMP2A mRNA expression was detected in EBV DNA-positive specimens. EBV early gene BARF1 mRNA was detected in 2 cases of EBV-positive SLE patients, and these 2 patients were also HHV-6 DNA positive. Thirty-eight patients were BcLF1 mRNA positive, and 33 of them were HHV-6 positive as well. These factors were associated (&#x3c7;<sup>2</sup>&#x2009;=&#x2009;15.734, P&#x2009;=&#x2009;0). The expression of the EBV immediate early gene BZLF1 was negative in all 75 EBV-positive SLE patients.</AbstractText><AbstractText Label="CONCLUSIONS">The results suggest that EBV infection might be related to the occurrence of SLE. Although there is no direct evidence that HHV-6 infection is associated with the development of SLE, EBV and HHV-6 infection may have a coacceleration effect in SLE patients. This study provides a new theoretical and experimental basis for the study of viral etiology and the prevention and treatment of SLE.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiaotong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Department of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, 110001, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Hui</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, 19 Jiangsu Road, Qingdao, 266003, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chunling</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The Department of Rheumatology and Immunology, The First Hospital of China Medical University, Shenyang, 110001, China. wuchling@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pathogeny Biology, Basic Medicine College, Qingdao University, Qingdao, 266071, China. qdzhangyan01@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Laboratory, Zibo Central Hospital, Zibo, 255036, China. qdzhangyan01@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086495">BARF1 protein, Human herpesvirus 4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004854" MajorTopicYN="N">Herpesvirus 4, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020031" MajorTopicYN="Y">Epstein-Barr Virus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015654" MajorTopicYN="Y">Herpesvirus 6, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019349" MajorTopicYN="Y">Roseolovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epstein&#x2012;Barr virus</Keyword><Keyword MajorTopicYN="N">Human herpesvirus 6</Keyword><Keyword MajorTopicYN="N">Latent gene</Keyword><Keyword MajorTopicYN="N">Lytic gene</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>0</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36782252</ArticleId><ArticleId IdType="pmc">PMC9926755</ArticleId><ArticleId IdType="doi">10.1186/s12985-023-01987-3</ArticleId><ArticleId IdType="pii">10.1186/s12985-023-01987-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Benseler SM, Silverman ED. Systemic lupus erythematosus. Pediatr Clin North Am. 2005;52(443&#x2013;467):vi.</Citation><ArticleIdList><ArticleId IdType="pubmed">15820375</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon C, Li CK, Isenberg DA. Systemic lupus erythematosus. Medicine. 2009;38:73&#x2013;80. doi: 10.1016/j.mpmed.2009.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mpmed.2009.10.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigante D, Esposito S. Infections and systemic lupus erythematosus: binding or sparring partners? Int J Mol Sci. 2015;16(8):17331&#x2013;17343. doi: 10.3390/ijms160817331.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms160817331</ArticleId><ArticleId IdType="pmc">PMC4581196</ArticleId><ArticleId IdType="pubmed">26230690</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N, Bassetto F, Doria A. Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol. 2010;87(3):385&#x2013;395. doi: 10.1189/jlb.0709517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0709517</ArticleId><ArticleId IdType="pubmed">20015961</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen PR, Kragstrup TW, Deleuran BW, Benros ME. Infections as risk factor for autoimmune diseases: a nationwide study. J Autoimmun. 2016;74:176&#x2013;181. doi: 10.1016/j.jaut.2016.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2016.05.013</ArticleId><ArticleId IdType="pubmed">27267460</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P, Rylance P, Roden D, Trela M, Tugnet N. Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus. 2014;23(6):596&#x2013;605. doi: 10.1177/0961203314531637.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314531637</ArticleId><ArticleId IdType="pubmed">24763543</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein&#x2013;Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019;19(1):23&#x2013;26. doi: 10.1007/s10238-018-0535-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-018-0535-0</ArticleId><ArticleId IdType="pmc">PMC6394567</ArticleId><ArticleId IdType="pubmed">30361847</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirdel A, Hashemzadeh K, Sahebari M, Rafatpanah H, Hatef M, Rezaieyazdi Z, Mirfeizi Z, Faridhosseini R. Is there any association between human lymphotropic virus Type I (HTLV-I) infection and systemic lupus erythematosus? An original research and literature review. Iran J Basic Med Sci. 2013;16(3):252&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3881250</ArticleId><ArticleId IdType="pubmed">24470872</ArticleId></ArticleIdList></Reference><Reference><Citation>Giardullo L, Corrado A, Maruotti N, Rotondo C, Cantatore FP. Rheumatological diseases in HIV infection. Curr Rheumatol Rev. 2021;17(3):271&#x2013;282. doi: 10.2174/1573397116999201208213717.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573397116999201208213717</ArticleId><ArticleId IdType="pubmed">33292153</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung JY, Suh CH. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med. 2017;32(3):429&#x2013;438. doi: 10.3904/kjim.2016.234.</Citation><ArticleIdList><ArticleId IdType="doi">10.3904/kjim.2016.234</ArticleId><ArticleId IdType="pmc">PMC5432804</ArticleId><ArticleId IdType="pubmed">28490724</ArticleId></ArticleIdList></Reference><Reference><Citation>Root-Bernstein R, Fairweather D. Complexities in the relationship between infection and autoimmunity. Curr Allergy Asthma Rep. 2014;14(1):407. doi: 10.1007/s11882-013-0407-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11882-013-0407-3</ArticleId><ArticleId IdType="pmc">PMC3926441</ArticleId><ArticleId IdType="pubmed">24352912</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen J, Rhodes G, Roudier J, Vaughan JH. Alteredimmune response to glycine-rich sequences of Epstein&#x2013;Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum. 1990;33:993&#x2013;1000. doi: 10.1002/art.1780330711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780330711</ArticleId><ArticleId IdType="pubmed">2164400</ArticleId></ArticleIdList></Reference><Reference><Citation>James JA, Scofield RH, Harley JB. Lupus humoral autoimmunity after short peptide immunization. Ann N Y Acad Sci. 1997;815:124&#x2013;127. doi: 10.1111/j.1749-6632.1997.tb52054.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1997.tb52054.x</ArticleId><ArticleId IdType="pubmed">9186649</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatini A, Bombardieri S, Migliorini P. Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein&#x2013;Barr virus-encoded nuclear antigen EBNA1. Eur J Immunol. 1993;23:1146&#x2013;1152. doi: 10.1002/eji.1830230525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830230525</ArticleId><ArticleId IdType="pubmed">8386666</ArticleId></ArticleIdList></Reference><Reference><Citation>James JA, Neas BR, Moser KL, Hall T, Bruner GR, Sestak AL, Harley JB. Systemic lupus erythematosus in adults is associated with previous Epstein&#x2013;Barr virus exposure. Arthritis Rheum. 2000;44:1122&#x2013;1126. doi: 10.1002/1529-0131(200105)44:5&lt;1122::AID-ANR193&gt;3.0.CO;2-D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200105)44:5&lt;1122::AID-ANR193&gt;3.0.CO;2-D</ArticleId><ArticleId IdType="pubmed">11352244</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasmussen NS, Draborg AH, Nielsen CT, Jacobsen S, Houen G. Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients. Scand J Rheumatol. 2015;44(2):143&#x2013;149. doi: 10.3109/03009742.2014.973061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/03009742.2014.973061</ArticleId><ArticleId IdType="pmc">PMC4389709</ArticleId><ArticleId IdType="pubmed">25562120</ArticleId></ArticleIdList></Reference><Reference><Citation>Broccolo F, Drago F, Cassina G, Fava A, Fusetti L, Matteoli B, Ceccherini-Nelli L, Sabbadini MG, Lusso P, Parodi A, Malnati MS. Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. J Med Virol. 2013;85(11):1925&#x2013;1934. doi: 10.1002/jmv.23670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23670</ArticleId><ArticleId IdType="pubmed">23983182</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarc&#xf3;n GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, S&#xe1;nchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG, Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G, Jr, Magder LS. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64(8):2677&#x2013;2686. doi: 10.1002/art.34473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.34473</ArticleId><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35:630&#x2013;40. doi: 10.1002/art.1780350606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780350606</ArticleId><ArticleId IdType="pubmed">1599520</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Tang X, Zhang S, Wang Y, Wang X, Zhao C, Luo B. Methylation and expression of retinoblastoma and transforming growth factor-&#x3b2;1 genes in Epstein&#x2013;Barr virus-associated and -negative gastric carcinomas. Gastroenterol Res Pract. 2012;2012:906017. doi: 10.1155/2012/906017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/906017</ArticleId><ArticleId IdType="pmc">PMC3447358</ArticleId><ArticleId IdType="pubmed">23008701</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Estel GJ, Alarcon GS, Scofield L, Reinlib L, Cooper GS. Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum. 2010;39(4):257&#x2013;268. doi: 10.1016/j.semarthrit.2008.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2008.10.007</ArticleId><ArticleId IdType="pmc">PMC2813992</ArticleId><ArticleId IdType="pubmed">19136143</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith PP, Gordon C. Systemic lupus erythematosus: clinical presentations. Autoimmun Rev. 2010;10(1):43&#x2013;45. doi: 10.1016/j.autrev.2010.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2010.08.016</ArticleId><ArticleId IdType="pubmed">20850569</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwata S, Tanaka Y. Association of viral infection with the development and pathogenesis of systemic lupus erythematosus. Front Med (Lausanne) 2022;25(9):849120. doi: 10.3389/fmed.2022.849120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.849120</ArticleId><ArticleId IdType="pmc">PMC8914279</ArticleId><ArticleId IdType="pubmed">35280878</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonavoglia A, Leone P, Prete M, Solimando AG, Guastadisegno C, Lanave G, Camero M, Martella V, Lo Muzio L, Racanelli V. Epstein&#x2013;Barr virus in salivary samples from systemic lupus erythematosus patients with oral lesions. J Clin Med. 2021;10(21):4995. doi: 10.3390/jcm10214995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10214995</ArticleId><ArticleId IdType="pmc">PMC8584540</ArticleId><ArticleId IdType="pubmed">34768514</ArticleId></ArticleIdList></Reference><Reference><Citation>Das P, Minz RW, Saikia B, Sharma A, Anand S, Singh H, Singh S. Association of human leucocyte antigen class ii, with viral load and immune response to Epstein&#x2013;Barr virus in adult and pediatric systemic lupus erythematosus patients. Lupus. 2022;31(9):1054&#x2013;1066. doi: 10.1177/09612033221100156.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033221100156</ArticleId><ArticleId IdType="pubmed">35607991</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu JJ, Chen DY, Hsieh CW, Lan JL, Lin FJ, Lin SH. Association of Epstein&#x2013;Barr virus infection with systemic lupus erythematosus in Taiwan. Lupus. 2007;16(3):168&#x2013;175. doi: 10.1177/0961203306075800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203306075800</ArticleId><ArticleId IdType="pubmed">17432101</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J Immunol. 2005;174(11):6599&#x2013;6607. doi: 10.4049/jimmunol.174.11.6599.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.174.11.6599</ArticleId><ArticleId IdType="pubmed">15905498</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole BD, Templeton AK, Guthridge JM, Brown EJ, Harley JB, James JA. Aberrant Epstein&#x2013;Barr viral infection in systemic lupus erythematosus. Autoimmun Rev. 2009;8(4):337&#x2013;342. doi: 10.1016/j.autrev.2008.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2008.12.008</ArticleId><ArticleId IdType="pmc">PMC2822456</ArticleId><ArticleId IdType="pubmed">19167523</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimber-Strobl U, Strobl LJ. EBNA2 and notch signalling in Epstein&#x2013;Barr virus mediated immortalization of B lymphocytes. Semin Cancer Biol. 2001;11(6):423&#x2013;434. doi: 10.1006/scbi.2001.0409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/scbi.2001.0409</ArticleId><ArticleId IdType="pubmed">11669604</ArticleId></ArticleIdList></Reference><Reference><Citation>Incaprera M, Rindi L, Bazzichi A, Garzelli C. Potential role of the Epstein&#x2013;Barr virus in systemic lupus erythematosus autoimmunity. Clin Exp Rheumatol. 1998;16(3):289&#x2013;294.</Citation><ArticleIdList><ArticleId IdType="pubmed">9631751</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu J, Wang X, Geng G, Xue X, Lin X, Zhu X, Sun L. The possible effect of B-cell epitopes of Epstein&#x2013;Barr virus early antigen, membrane antigen, latent membrane protein-1, and -2A on systemic lupus erythematosus. Front Immunol. 2018;9:187. doi: 10.3389/fimmu.2018.00187.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00187</ArticleId><ArticleId IdType="pmc">PMC5819577</ArticleId><ArticleId IdType="pubmed">29497417</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller CL, Longnecker R, Kieff E. Epstein&#x2013;Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol. 1993;67(6):3087&#x2013;3094. doi: 10.1128/jvi.67.6.3087-3094.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.67.6.3087-3094.1993</ArticleId><ArticleId IdType="pmc">PMC237645</ArticleId><ArticleId IdType="pubmed">7684459</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Nicholas MW, Conway KL, Sen P, Diz R, Tisch RM, Clarke SH. EBV latent membrane protein 2A induces autoreactive B cell activation and TLR hypersensitivity. J Immunol. 2006;177(5):2793&#x2013;2802. doi: 10.4049/jimmunol.177.5.2793.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.5.2793</ArticleId><ArticleId IdType="pubmed">16920914</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenzie J, El-Guindy A. Epstein&#x2013;Barr virus lytic cycle reactivation. Curr Top Microbiol Immunol. 2015;391:237&#x2013;261.</Citation><ArticleIdList><ArticleId IdType="pubmed">26428377</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanlon P, Avenell A, Aucott L, Vickers MA. systematic review and meta-analysis of the sero-epidemiological association between Epstein&#x2013;Barr virus and systemic lupus erythematosus. Arthritis Res Ther. 2014;16(1):R3. doi: 10.1186/ar4429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4429</ArticleId><ArticleId IdType="pmc">PMC3978841</ArticleId><ArticleId IdType="pubmed">24387619</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZX, Zeng S, Wu HX, Zhou Y. The risk of systemic lupus erythematosus associated with Epstein&#x2013;Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019;19:23&#x2013;36. doi: 10.1007/s10238-018-0535-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10238-018-0535-0</ArticleId><ArticleId IdType="pmc">PMC6394567</ArticleId><ArticleId IdType="pubmed">30361847</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonnebeck M, Krueger GR, Braun M, Fischer M, Koch B, Ablashi DV, Balachandran N. Human herpesvirus 6 infection may predispose cells to superinfection by other viruses. In Vivo. 1991;5(3):255&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pubmed">1654148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagawa S, Miguki M, Onoi U, Nakamura Y, Nozima J, Yoshida H, Kondo K, Mukai T, Yamanishi K, Kitani T. Transformation of large granular lymphocytic leukemia during the course of a reactivated HHV 6 infection. Leukemia. 1992;6(5):465&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pubmed">1317489</ArticleId></ArticleIdList></Reference><Reference><Citation>Flamand L, Menezes J. Cyclic AMP-responsive-element-dependent activation of Epstein&#x2013;Barr virus Zebra promoter by human herpesvirus 6. J virol. 1996;70:1784&#x2013;1791. doi: 10.1128/jvi.70.3.1784-1791.1996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.70.3.1784-1791.1996</ArticleId><ArticleId IdType="pmc">PMC190004</ArticleId><ArticleId IdType="pubmed">8627701</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>